CTRI/2024/07/070510
Not yet recruiting
未知
Observational study to assess efficacy and safety of Bifidobacterium longumW11 plus Fructooligosaccharide combination in patients with irritable bowel syndrome (IBS) - NI
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: K519- Ulcerative colitis, unspecified
- Sponsor
- Abbott India Ltd
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients of either sex, aged between 18 and 60 years
- •OPD Patients with confirmed diagnosis of IBS with any of the three subtypes (viz IBS D/IBS C/IBS M)
- •Patients with no improvement in symptoms despite treatment with antispasmodics
Exclusion Criteria
- •Patients will be excluded if they have severe respiratory insufficiency organic brain damage sleep apnea syndrome severe acute or chronic
- •hepatic insufficiency (risk of occurrence of encephalopathy) myasthenia gravis chronic psychosis major depressive episodes
- •phobic or obsessional states or dementia
- •Patients with other pre\-existing GI disorders GI surgery abnormal upper and lower GI endoscopy finding family history of colon cancer or inflammatory bowel disease symptoms that discriminate lower GI organic diseases from IBS such as blood in stool nighttime symptoms
- •that cause sleep disturbance unintentional weight loss or change in typical IBS symptoms such as new and/or different pain and alcohol or drug\-dependency
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Study to assess safety and efficacy of Inj Sepsivac in patients of Covid-19CTRI/2020/05/025350R D Gardi Medical College
Not yet recruiting
Not Applicable
An observational study of Controlled Release Nitroglycerin in patients with angina.CTRI/2018/10/016215Care Lifescience Private Limited
Recruiting
Not Applicable
Observational study on HAL lower limb model, non medical for non-acute strokeon-acute strokeStroke, non-acute, gait disturbanceD020521JPRN-jRCT1030220498akajima Takashi10
Recruiting
Phase 1
Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients with Chronic hepatitis Dhepatitis DTherapeutic area: Diseases [C] - Virus Diseases [C02]CTIS2023-504414-29-00Karolinska University Hospital400
Recruiting
Not Applicable
An observational study of the safety and efficacy of nivolumab as adjuvant treatment for esophageal cancer using the Comprehensive Registry of Esophageal Cancer in the National Clinical Database.Esophageal cancer or esophagogastric cancerJPRN-UMIN000050925Japanese Foundation For Cancer Research1,750